ロード中...
A 12-Week Randomized Controlled Trial of Twice-Daily Intranasal Oxytocin for Social Cognitive Deficits in People with Schizophrenia
Social cognition is impaired in people with schizophrenia and these deficits are strongly correlated with social functioning. Oxytocin is a hypothalamic peptide that contributes to maternal infant bonding and has diverse pro-social effects in adults. This study tested the hypothesis that 12 weeks of...
保存先:
| 出版年: | Schizophr Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5474129/ https://ncbi.nlm.nih.gov/pubmed/28094169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2017.01.008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|